Russian researchers have developed a nanodrug that can identify a brain tumour during the first stage and can subsequently be used for the diagnosis of other cancer types as well. The research team led by Alexander Majouga head of the biomedical nanomaterials laboratory at Russia s National University of Science and Technology is planning to start clinical trials of the new nanoagent in 2018 an official statement said. But not only does this technology help diagnose early stage cancers in the future it will also be used for targeted drug transport directly aimed at tumour cells the researchers said. After
